Townsend Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,421
Closed -$742K 205
2023
Q2
$742K Sell
1,421
-70
-5% -$37.8K 0.36% 57
2023
Q1
$860K Sell
1,491
-417
-22% -$235K 0.44% 51
2022
Q4
$1.05M Buy
1,908
+64
+3% +$33.9K 0.53% 52
2022
Q3
$935K Sell
1,844
-215
-10% -$120K 0.53% 51
2022
Q2
$1.12M Sell
2,059
-5
-0.2% -$2.75K 0.58% 47
2022
Q1
$1.22M Buy
2,064
+425
+26% +$244K 0.6% 47
2021
Q4
$1.09M Buy
+1,639
New +$1.02M 0.52% 50

Other funds holding TMO

Townsend Asset Management's TMO Position: Q3 2023 in Review

Townsend Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 1,421 shares — an estimated $742K sold.

Townsend Asset Management first reported a position in TMO in Q4 2021 and held it in 7 quarters. The position peaked at $1.22M in Q1 2022. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Townsend Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Townsend Asset Management sold 1,421 Thermo Fisher Scientific shares in Q3 2023, an estimated $742K.
  • Townsend Asset Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 7 quarters.
  • Townsend Asset Management's Thermo Fisher Scientific position peaked at $1.22M in Q1 2022.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Townsend Asset Management's 13F filing for Q3 2023, filed 20 Oct 2023.